Related Experiment Videos
Congenital cystic adenomatoid malformation type 4
S van Koningsbruggen1, F Ahrens, M Brockmann
1Department of Pediatrics, Children's University Hospital Cologne, Cologne, Germany.
Pediatric Pulmonology
|December 18, 2001
Summary
Congenital cystic adenomatoid malformation (CCAM) type 4 was diagnosed in an infant initially suspected of having congenital lobar emphysema (CLE). Prompt resection and lifelong follow-up are recommended for CCAM type 4 due to potential associated anomalies and malignancy risks.
Area of Science:
- Pediatric Pulmonology
- Thoracic Surgery
- Developmental Biology
Background:
- Congenital anomalies of the lung present diagnostic challenges in neonates.
- Congenital lobar emphysema (CLE) and congenital cystic adenomatoid malformation (CCAM) are distinct entities requiring specific management considerations.
Observation:
- A 9-day-old infant presented with respiratory distress and failure to thrive.
- Chest X-ray revealed left lung hyperlucency, leading to a presumptive diagnosis of CLE.
- Surgical resection of the affected lung segment was performed.
Findings:
- Histological examination confirmed CCAM type 4, not CLE.
- CCAM type 4 diagnosis necessitates evaluation for associated anomalies and long-term risks.
- The exact frequency of associated anomalies and malignancy risk for CCAM type 4 remain unclear.
Implications:
- Accurate diagnosis of CCAM type 4 is crucial for appropriate patient management.
- Prompt surgical resection is advised due to potential malignancy risk, even in asymptomatic cases.
- Lifelong follow-up is recommended for patients who undergo CCAM resection in early childhood.